FDA Authorization of Historic Phase I Clinical Trial Using All-Natural Psychedelic Compounds and Direct Psilocin Administration for the First Time Granted First and Only Patent for Extraction and Standardization of Natural Psilocybin Health Canada Dealer’s License Enables Production and Distribution of All Natural cGMP-Grade Psychedelic Supply from its Facilities VANCOUVER, BC, Nov. 15, 2021 /CNW/


Previous articleRed Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory
Next articleMindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures